|
Market Analysis Reports of TGF-alpha
|
TGF-ALPHA (CAS 105186-99-0) Market Research Report 2025 BAC Reports offers its clients in-depth market research of chemical industry products on the global and regional markets (North & Latin America, Asia Pacific, European Union, Russia and CIS).
Global Market Report of TGF-ALPHA (CAS 105186-99-0) December 2024
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-?/R, CXCR4, CSF-1R, CD47-SIRP?, Adenosine, STING & Others ... Tumor Microenvironment Modulation via IDO, TGF-?/R, CXCR4, CSF-1R, CD47-SIRP ... 2,3-dioxygenase TDO (Tryptophan 2,3 dioxygenase) TGF-?/R (Transforming Growth Factor beta/ ... – SIRP? (Signal Regulatory Protein Alpha) Adenosine Pathway: Adenosine 2A Receptor ( ...
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-?, CXCR4, CSF-1R, CD47-SIRP?, adenosine pathway & STING 2018 ... Tumor Microenvironment Modulation via IDO, TGF-?, CXCR4, CSF-1R, CD47-SIRP ... 2,3-dioxygenase TDO (Tryptophan 2,3 dioxygenase) TGF-?/R (Transforming Growth Factor beta/ ... CD47 – SIRP? (Signal Regulatory Protein Alpha) Adenosine Pathway: Adenosine 2A Receptor ( ...
Glioblastoma - Pipeline Insight, 2022 ... Therapeutics Trabedersen is an antisense against TGF-?2 – for the treatment of solid ... other transforming growth factor beta 2 (TGF-?2) overexpressing malignancies (e.g., prostate ... from the effects of pathogenic alpha-synuclein protein aggregation and ...
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators ... Tumor Microenvironment Modulation via IDO, TGF-?, CXCR4, CSF-1R, CD47-SIRP ... 2,3-dioxygenase TDO (Tryptophan 2,3 dioxygenase) TGF-?/R (Transforming Growth Factor beta/ ... CD47 – SIRP? (Signal Regulatory Protein Alpha) Adenosine Pathway: Adenosine 2A Receptor ( ...
Competitor Analysis: Inhibitory and Stimulatory Immunomodulators in Immuno-Oncology ... Tumor Microenvironment Modulation via IDO, TGF-?/R, CXCR4, CSF-1R, CD47-SIRP ... 2,3-dioxygenase TDO (Tryptophan 2,3 dioxygenase) TGF-?/R (Transforming Growth Factor beta/ ... – SIRP? (Signal Regulatory Protein Alpha) Adenosine Pathway: Adenosine 2A Receptor ( ...
Benign Prostatic Hyperplasia - Pipeline Insight, 2021 ... of medications for BPH are alpha-adrenergic blockers and 5-alpha reductase inhibitors. 'Benign ... fibrosis, and it also modulates TGF?1 mRNA expression and TGF?1 levels to prevent and ...
2019-2023 Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth ...
2014 Analysis of the Tumor Markers: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers Complete report $28,500. DataPack (test volumes, sales forecasts, supplier shares) $9,800. Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years Examines trends in the U.S., Europe ...
Future French Tumor Marker Testing Market Outlook Highlights Comprehensive 585-page analysis of the French tumor marker testing market. Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
Future German Tumor Marker Testing Market Outlook Highlights Comprehensive 585-page analysis of the German tumor marker testing market. Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
Future Italian Tumor Marker Testing Market Outlook Highlights Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
Future Japanese Tumor Marker Testing Market Outlook Highlights Comprehensive 590-page analysis of the Japanese tumor marker testing market. Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
Future Spanish Tumor Marker Testing Market Outlook Highlights Comprehensive 565-page analysis of the Spanish tumor marker testing market. Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market ...
Future UK Tumor Marker Testing Market Outlook Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during ...
Future US Tumor Marker Testing Market Outlook Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during ...
Emerging Tumor Markers and Companies Developing Innovative Technologies and Products Highlights Comprehensive 260-page market and technological assessment. Medical rationale and diagnostic prospects for major categories of both circulating and cellular tests, such as : Biochemical Markers Oncogenes Growth Factors Hormones Colony ...
2012 Global Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the ...
2012 France Cancer Diagnostics Market Outlook: Growth Opportunities and Strategies This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant ...
|
|
|